Last week Europe’s first Longevity AI Consortium (LAIC) launched at King's College London with strategic and financial support from Deep Knowledge Group and the Biogerontology Research Foundation.
By Stefan Hascoet, Partner at Longevity.Capital
Artificial Intelligence (AI) for Longevity is an underrepresented sector in the Longevity Industry despite having more potential to increase Healthy Longevity in the short term than any other sector. The Longevity AI Consortium will work to facilitate the shift from treatment to prevention and from preventive medicine to real-world precision health. The initial aim will be to identify novel longevity and healthy ageing biomarkers to accelerate diagnosis of age-related health decline. Then researchers will develop personalized physical, mental and financial health to better implement and promote healthy lifestyles for longevity, such as modifying patterns in sleep, nutrition, physical activity, environmental exposure and financial planning.
The Consortium will serve as the leading R&D hub and industry-academic hotspot for advanced AI-driven AI-driven personalized preventive diagnostics, prognostics and therapeutics.This represents a paradigm shift from treatment to prevention and a new frontier - from precision medicine to precision health, enabling the UK to become the #1 global hub for the application of AI to Longevity and Precision Health. Precision Health through AI will be developed by a combination of AI-Driven Precision Diagnostics, AI-Driven Advanced Prognostics, Personalised Treatment Optimization, and AI-Driven Preventative Treatment. In addition, the Longevity AI Consortium also plans on dedicating resources to R&D in other niches where the science is ahead of the funding: e.g. microbiome diagnostics and therapeutics, recent advancements and innovations in advanced cosmetics in particular.
As part of its continuing development efforts over the next several years, the Consortium will expand to include centers in Switzerland, Israel, Singapore, United States and Japan through a £7 million commitment from Deep Knowledge Ventures. The first country where the Consortium is expanding to is Switzerland. The LAIC is developing collaborative research projects with Dynamics of Healthy Ageing and the Digital Society Initiative at the University of Zurich initially funded by Deep Knowledge Ventures. The collaboration will utilize AI technologies to predict future cognitive ability of individuals using multimodal neuroimaging and risk factor data.
The lead academic in Zurich will be Mike Martin, Director of DynAge and DSI, and the London team will be Richard Siow, Director of ARK, in collaboration with colleagues at the Institute of Psychiatry, Psychology & Neuroscience. By the end of 2020 we expect LAIC to have established several collaborative projects with University of Zurich, including some funded through the KCL Longevity AI Accelerator. The joint R&D between Ageing Research at Kings and University of Zurich forms the first phase of the global Longevity AI Consortium that will be extended to Israel, Singapore, Japan and the US.
A major component of the Switzerland-base AI for Longevity Center, besides cutting-edge Longevity R&D and biomarkers of Longevity research and clinical translation, will be the concept of developing AI-enabled technologies for extended wealthspan: financial wellness over prolonged healthspans.
The planned development of AI Centers for Financial Wellness will enable financial stability over extended periods of healthy Longevity for Swiss citizens, Applying Advances in WealthTech and AgeTech. Given both its status as an international BioTech epicentre, combined with its reputation for being one of the most progressive countries in terms of its financial industry and FinTech sector, the prospects for Switzerland to lead the world in the development of its Longevity Financial Industry are extremely strong.
As a core component of its mission to develop Switzerland into a leading international Longevity Financial Industry hub, Longevity Swiss Foundation also plans on roadmapping the development of AI Centres for Financial Wellness. Whereas the proposed AI Centres for Longevity would focus on optimizing health, this centre would focus on the application of AI to the creation of methods and technologies to promote wellness in the elderly in all aspects of life besides health, ranging from financial wellness, continuing education, happiness, psychological well being, neuroplasticity and active social involvement.
The Recent Launch of Longevity Swiss Foundation: Making Switzerland a Leader of International Longevity Policy
Another development related to Deep Knowledge Group’s increasing interest in the Swiss Longevity sphere is the recent launch of the Longevity Swiss Foundation, a leading Geneva-based Longevity Policy Non-profit and Think Tank working to leverage the national strengths and potentials of Switzerland in order to turn the nation into a world-leading Longevity Hub through the coordinated development of Longevity Politics and Governance, the Longevity BioTech Industry, Preventive Medicine, Precision Health and the emerging Longevity Financial Industry.
Leveraging Switzerland’s existing reputation as a hub for independent international policy organizations like the World Economic Forum, the United Nations, UNESCO, the World Health Organization and Others, Swiss Longevity Foundation aims to turn Switzerland into the leading international hub for cross-sector and cross-nation Longevity Development projects and initiatives, including:
- Interfacing with Swiss Government Agencies and Representatives to Build a National Swiss Longevity Development Strategy
- Supporting the Nation-Wide Launch of Swiss AI Centres
- for Precision Health and AI Centres for Financial Wellness
- Dedicated to Turning Switzerland into an International Longevity, Preventive Medicine and Precision Health Hub
Longevity Swiss Foundation will work with the participation of proactive corporate and institutional partners to interface with relevant Swiss governmental ministries, departments, agencies and members of Swiss Parliament to establish a National Swiss Longevity Development Framework, as well as the establishment of a parliamentary body equivalent to the United Kingdom’s All-Party Parliamentary Group on Longevity, to transform the economic burden of an aging population into a source of economic growth and increased national Healthy Longevity.
Longevity Swiss Foundation is interested in cooperation, collaboration and initiating dialogue from a number of relevant organizations actively involved in Swiss governance, ranging from government ministries, agencies and departments, to relevant policy-focused NGOs and think-tanks, to members of Swiss Parliament in order to establish a framework for the coordinated development of the nation’s Longevity politics and governance sphere.
In order to bootstrap its activities in the realms of Longevity policy, politics, governance and synergetic industry development, Longevity Swiss Foundation is seeking donations from key institutional and individual sponsors that are keen to see the nation manifest its latent strengths and prospects, and become the leading Longevity nation that it has the potential to be.
Longevity Swiss Foundation plans to work with a number of key Swiss Longevity Industry participants and stakeholders to develop a framework and blueprint for a Government-led National Longevity Development Plan to increase the national Health-Adjusted Life Expectancy (HALE) of all Swiss citizens. The scope of this plan also includes financial reform to boost Swiss GDP and reduce the economic burden of an aging population. In order to support this sphere of activity, Swiss Longevity Foundation is keen to work alongside large Swiss financial institutions including pension funds, insurance companies, private wealth banks and asset management firms to roadmap initiatives and policy proposals capable of turning the problem of ageing population into the economic opportunity of Healthy Longevity.of Longevity policy, politics, and scientific R&D.
- Switzerland’s existing strengths in BioTech and BioPharma, Industry-Academic Collaboration, International Policy, FinTech and the Financial Industry make it the perfectly-poised hotspot to rapidly develop the full scope of the Longevity Industry Ecosystem, encompassing biomedicine, tech and finance
- Its specific strengths in FinTech and progressive financial products, services and solutions give it stronger prospects than any other country in the world to become the global leader specifically in the area of the Longevity Financial Industry, encompassing novel financial products and services for the elderly, fully integrated AgeTech - WealthTech solutions, and sophisticated AI and data-driven platforms for maintaining weathspan over extended periods of healthspan
- Deep Knowledge Group is utilizing its many resources to help advance this agenda, and secure Switzerland’s place as the Longevity Valley of the near-future, by supporting the full scope of Longevity industry developments in the nation, including the Longevity Biomedicine and Financial Industries via the activities of its Switzerland-based subsidiary, Deep Knowledge Swiss, AI for Longevity via the activities of the upcoming Swiss branch of the Longevity AI Consortium, and the domain of International Longevity Policy via the activities of the Swiss Longevity Foundation.
The Swiss Longevity Valley and its unique strengths
The Swiss Longevity Valley: How Switzerland Will Become a Global Longevity Financial MegaHub by 2025
Defining the Longevity Industry: The Biggest and Most Complex Industry In Human History